NCT02662634 A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT02620280 Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1 Status COMPLETED Phase PHASE3
NCT02328105 LCI-LUN-ABR-001: Carbo With Nab-Paclitaxel in Patients With Advanced NSCL Cancer Status COMPLETED Phase PHASE2
NCT02303977 Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy Status COMPLETED Phase PHASE2
NCT02207465 A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02124369 Pancreatic Resectability in Cancers With Known Limited Extension (PRICKLE) Status TERMINATED Phase PHASE2
NCT02073916 T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT02073487 Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel Status COMPLETED Phase PHASE2
NCT02030860 A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01978184 Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine Status COMPLETED Phase PHASE2
NCT01938833 Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01933061 Study to Determine Efficacy and Safety of CC-486 With Nab-Paclitaxel Versus Nab-Paclitaxel in Patients With Chemotherapy naïve Metastatic Melanoma Status WITHDRAWN Phase PHASE2
NCT01839799 A Randomized Phase II/Genomic Trial of Two Chemotherapy Regimens in Patients With Resected Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE2
NCT01822314 Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer Status COMPLETED Phase PHASE3
NCT01730586 Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas Status COMPLETED Phase PHASE2
NCT01715142 Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01693276 Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT01647672 Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer Status UNKNOWN Phase PHASE2/PHASE3